NCT06225648

Brief Summary

Threonine is an essential amino acid and must be obtained from the diet. The body's capacity to maintain adequate mucin synthesis is directly related to the bioavailability of certain amino acids, including threonine, serine and proline (1). Moreover, the rate of mucin synthesis has been demonstrated to be directly related to the availability of dietary threonine in healthy rats (2) and piglets (3,4). Intestinal inflammation is known to increase gastrointestinal threonine uptake and mucin synthesis in enterally fed minipigs (5). Additionally, in animals, mucin function/barrier has been shown to decline with age, leaving them more susceptible to bacterial penetration. Thus, with advancing age (6), a higher dietary supply of threonine may be needed for maintaining intestinal mucosal health. Despite this, the current threonine requirement is based on studies conducted exclusively in young adults. Thus, there is a need to determine the threonine requirement directly in older adults.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
Completed

Started Feb 2024

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

February 3, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

1.7 years

First QC Date

January 16, 2024

Last Update Submit

May 23, 2025

Conditions

Keywords

elderlyhealthythreonine requirementindicator amino acid oxidationstable isotopes

Outcome Measures

Primary Outcomes (1)

  • Determination of threonine requirements in adults >60 years of age

    To measure the threonine requirement investigators will collect breath samples from participants. From these samples, investigators will measure the amount of amino acids oxidized and how much is retained in the body when graded intakes of threonine are consumed by the participants consuming a controlled diet.

    up to 24 months

Study Arms (1)

Threonine in Adults > 60

EXPERIMENTAL

Threonine: all subjects will receive up to 7 threonine test levels, in random order.

Other: threonine

Interventions

There are 7 different threonine test levels ranging from 5 to 45 mg of threonine per kilogram body weight per day.

Threonine in Adults > 60

Eligibility Criteria

Age60 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consent provided
  • Aged 60 to 90 years old
  • In good general health as evidenced by medical history, physical health and blood draw
  • Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine
  • Willingness to participate in the study.
  • BMI \<30 kg/m2.

You may not qualify if:

  • Presence of chronic disease and/or acute illness known to affect protein/amino acid metabolism (e.g. HIV, diabetes, cancer, liver or kidney disease, acute cold or flu)
  • Taking medications known to affect protein/AA metabolism (e.g. steroids)
  • Inability to tolerate the diet (i.e. allergy)
  • Significant weight loss during the past month or consumption of weight reducing diets.
  • Significant caffeine consumption (\>2 cups per day)
  • Significant consumption of alcohol (\>1 drink per day i.e. 1 beer or ½ glass of wine).
  • Unwilling to have blood drawn from a venous access, or using a ventilated hood indirect calorimeter for the purposes of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

RECRUITING

MeSH Terms

Interventions

Threonine

Intervention Hierarchy (Ancestors)

Amino Acids, EssentialAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Neutral

Study Officials

  • Glenda Courtney-Martin, MSc, PhD, RD

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alyssa Paoletti, PhD, MSc

CONTACT

Mahroukh Rafii, BSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Associate Scientist

Study Record Dates

First Submitted

January 16, 2024

First Posted

January 26, 2024

Study Start

February 3, 2024

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations